No-Diabetic nephropathy (n = 844) | Diabetic nephropathy (n = 138) | P | |
---|---|---|---|
Age | 56.82 ± 14.09 | 59.10 ± 12.37 | 0.027 |
Sex | 0.517 | ||
Male | 453 (53.67) | 96 (51.06) | |
Female | 391 (43.33) | 92 (48.94) | |
Duration of diabetes | 4.00 (0.00–10.00) | 9.00 (2.00–15.00) | < 0.001 |
BMI | 25.20 ± 3.84 | 25.70 ± 3.89 | 0.109 |
Smoking | 268 (31.75) | 63 (33.51) | 0.641 |
Drinking | 234 (27.73) | 56 (29.79) | 0.569 |
SBP | 139.04 ± 23.43 | 146.56 ± 25.50 | < 0.001 |
HbA1c | 9.63 ± 2.41 | 9.50 ± 2.26 | 0.546 |
< 7% | 57 (6.75) | 20 (10.64) | < 0.001 |
≥ 7% | 428 (50.71) | 126 (67.02) | |
Lack | 359 (42.54) | 42 (22.34) | |
Triglyceride | 2.03 ± 1.51 | 2.13 ± 1.80 | 0.496 |
< 1.7 | 315 (37.32) | 68 (36.17) | 0.106 |
≥ 1.7 | 284 (33.65) | 77 (40.96) | |
Lack | 245 (29.03) | 43 (22.87) | |
HDL-C | 1.07 ± 0.34 | 1.15 ± 0.39 | 0.01 |
≥ 1 in male or ≥ 1.3 in female | 192 (22.75) | 58 (30.85) | 0.038 |
< 1 in male or < 1.3 in female | 404 (47.87) | 87 (46.28) | |
Lack | 248 (29.38) | 43 (22.87) | |
LDL-C | 2.85 ± 0.97 | 3.05 ± 1.17 | 0.042 |
< 2.6 | 254 (30.09) | 56 (29.79) | 0.133 |
≥ 2.6 | 342 (40.52) | 89 (47.34) | |
Lack | 248 (29.38) | 43 (22.87) | |
Antidiabetic drugs use | 686 (81.28) | 181 (96.28) | < 0.001 |